DELUCCIA ROBERT J - 27 Jul 2022 Form 4 Insider Report for Acurx Pharmaceuticals, Inc. (ACXP)

Role: Director, 10%+ Owner
Signature: /s/ Kostantinos Skordalos, Power of Attorney For: Robert J. DeLuccia
Issuer symbol: ACXP
Transactions as of: 27 Jul 2022
Net transactions value: +$75,001
Form type: 4
Filing time: 29 Jul 2022, 17:02:07 UTC
Previous filing: 04 Jan 2024
Next filing: 24 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ACXP	Common Stock	Purchase	$75,001	+19,737	+1.9%	$3.80	1,051,198	27 Jul 2022	Direct
holding	ACXP	Common Stock						3,847	27 Jul 2022	By spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ACXP	Warrants for Common Stock	Purchase	$0	+19,737		$0.000000	19,737	27 Jul 2022	Common Stock	19,737	$3.55	Direct
transaction	ACXP	Warrants for Common Stock	Purchase	$0	+19,737		$0.000000	19,737	27 Jul 2022	Common Stock	19,737	$3.55	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.